论文部分内容阅读
食管胃交界腺癌(adenocarcinoma of the esophagogastric junction,AEG)由于特殊的解剖位置,既有别于食管癌,又不同于胃癌,但又兼具两者特点,其生物学行为特殊,在全球范围内发病率逐年上升~([1])。第7版国际TNM分期,首次将AEG作为一种相对独立的疾病介绍~([2])。关于AEG分型、TNM分期、手术切除范围及手术方式及新辅助治疗等问题仍存较大争议。一、AEG的分型与TNM分期自1998年,国际上广泛接受了德国人提出的
Due to its special anatomical location, adenocarcinoma of the esophagogastric junction (AEG) is different from esophageal cancer, but different from gastric cancer, but both of them have special biological behavior and are widely used in the world The incidence increases year by year ~ ([1]). The seventh edition of the International TNM staging, for the first time AEG as a relatively independent disease introduced ~ ([2]). On the AEG classification, TNM staging, surgical resection range and surgical methods and neoadjuvant treatment and other issues remain controversial. First, AEG classification and TNM staging Since 1998, widely accepted by the German international